The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status
Authors:
Open Access
- 15 February 2021
- journal article
- research article
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 48 (1) , 79-84
Abstract
This study aimed to compare perinatal outcomes, including nonreassuring fetal status, according to antenatal corticosteroid therapy (ACT) use during late-preterm and early-term pregnancies. This was a retrospective cohort study of women with singleton pregnancies who were at risk of late-preterm (34-36+6 weeks) birth or early-term (37-38+6 weeks) scheduled cesarean section from August 2017-July 2019. ACT was administered until June 2018, after which a policy was implemented such that ACT was not used for pregnant women in the above circumstances. Women were grouped based on whether they delivered before or after the policy change and were subdivided into late-preterm birth and early-term scheduled cesarean section groups to reduce variations in newborn outcomes. Multivariable logistic regression was used to determine whether the use of antenatal corticosteroids increased the odds of perinatal outcomes. In total, 216 women (215 neonates, 1 stillborn) were included. In the late-preterm delivery group, the rate of nonreassuring fetal status was significantly higher in the antenatal corticosteroid group than in the non-corticosteroid group (33.3% vs 12.0%, P = 0.017). In the early-term delivery group, the rate was non-significantly higher in the antenatal corticosteroid use group (19.0% vs 6.3%, P = 0.091). In the multivariable logistic regression, ACT was associated with an increased risk of nonreassuring fetal status (P = 0.025) and a reduced incidence of transient tachypnea of the newborn (TTN) (P = 0.011). We determined for the first time that ACT in late-preterm and early-term pregnancy is associated with nonreassuring fetal status. Here, ACT in late-preterm and early-term pregnancy had no benefit beyond decreasing the TTN rate.Keywords
This publication has 12 references indexed in Scilit:
- Antenatal corticosteroid administration is associated with decreased growth of the fetal thymus: a prospective cohort studyJournal of Perinatology, 2019
- Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth RegisterPLOS Medicine, 2019
- Oligohydramnios is an independent risk factor for perinatal morbidity among women with pre-eclampsia who delivered pretermThe Journal of Maternal-Fetal & Neonatal Medicine, 2017
- The role of prenatal steroids at 34–36 weeks of gestationArchives of Disease in Childhood - Fetal and Neonatal Edition, 2017
- Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trialsBMJ, 2016
- Committee Opinion No.677: Antenatal Corticosteroid Therapy for Fetal MaturationObstetrics & Gynecology, 2016
- Antenatal Betamethasone for Women at Risk for Late Preterm DeliveryNew England Journal of Medicine, 2016
- FIGO consensus guidelines on intrapartum fetal monitoring: CardiotocographyInternational Journal of Gynecology & Obstetrics, 2015
- Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trialBMJ, 2011
- Effect of Betamethasone Administration on Fetal Heart Rate Tracing: A Blinded Longitudinal StudyFetal Diagnosis and Therapy, 2005